CAH vs MCRB · P/E 35, rev $254.25B vs rev $1.1M
Cardinal Health Inc (CAH) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the CAH and MCRB stock pages for the full models.
Not investment advice.